Satellos Bioscience MSLE
NASDAQ MSLE
$6.84 -0.16 (-2.29%)
As of: Oct 21, 2026 · 10:53 AM EDT

Satellos Bioscience (MSLE) Assets (2023 - 2026)

Updated

Satellos Bioscience (MSLE) reported Assets of $65.77 million for the quarter ended Jun 30, 2026, down 12.6% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Assets (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Satellos Bioscience posted Assets of $31.89 million, down 37.2% from the prior year.

  • By year, Assets came in at $50.75 million in the year ended Dec 31, 2024 (+51.5%) and $33.49 million in the year ended Dec 31, 2023.
  • Five-year quarterly Assets spans a low of $31.89 million in the quarter ended Dec 31, 2025 and a high of $75.23 million in the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,134.61 Bn 1,103.20 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 616.25 Bn 534.77 Bn 17.26 Bn 201.06 Bn
3 AbbVie 501.45 Bn 474.56 Bn 12.70 Bn 135.12 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.44 Bn 235.12 Bn 12.86 Bn 115.83 Bn
7 Amgen 235.87 Bn 191.27 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 49.36 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 201.13 Bn
10 Satellos Bioscience 99.84 Mn -108.30 Mn - 65.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.77 Mn
Mar 31, 2026 75.23 Mn
Dec 31, 2025 31.89 Mn
Dec 31, 2024 50.88 Mn
Dec 31, 2023 33.48 Mn
API Access

Satellos Bioscience Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=MSLE&period=max&api_key=YOUR_API_KEY